1. Home
  2. RNAC vs LMNR Comparison

RNAC vs LMNR Comparison

Compare RNAC & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNAC
  • LMNR
  • Stock Information
  • Founded
  • RNAC 2007
  • LMNR 1893
  • Country
  • RNAC United States
  • LMNR United States
  • Employees
  • RNAC N/A
  • LMNR N/A
  • Industry
  • RNAC Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • RNAC Health Care
  • LMNR Consumer Staples
  • Exchange
  • RNAC Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • RNAC 264.7M
  • LMNR 291.1M
  • IPO Year
  • RNAC 2016
  • LMNR N/A
  • Fundamental
  • Price
  • RNAC $10.00
  • LMNR $15.81
  • Analyst Decision
  • RNAC Strong Buy
  • LMNR Hold
  • Analyst Count
  • RNAC 7
  • LMNR 1
  • Target Price
  • RNAC $41.00
  • LMNR $23.00
  • AVG Volume (30 Days)
  • RNAC 76.4K
  • LMNR 71.1K
  • Earning Date
  • RNAC 05-08-2025
  • LMNR 06-09-2025
  • Dividend Yield
  • RNAC N/A
  • LMNR 1.90%
  • EPS Growth
  • RNAC N/A
  • LMNR N/A
  • EPS
  • RNAC N/A
  • LMNR 0.43
  • Revenue
  • RNAC $34,173,000.00
  • LMNR $186,077,000.00
  • Revenue This Year
  • RNAC N/A
  • LMNR N/A
  • Revenue Next Year
  • RNAC N/A
  • LMNR $11.90
  • P/E Ratio
  • RNAC N/A
  • LMNR $36.96
  • Revenue Growth
  • RNAC 31.91
  • LMNR 2.39
  • 52 Week Low
  • RNAC $8.46
  • LMNR $14.80
  • 52 Week High
  • RNAC $41.87
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • RNAC 43.07
  • LMNR 44.38
  • Support Level
  • RNAC $8.46
  • LMNR $15.13
  • Resistance Level
  • RNAC $10.10
  • LMNR $15.93
  • Average True Range (ATR)
  • RNAC 0.60
  • LMNR 0.46
  • MACD
  • RNAC 0.07
  • LMNR 0.06
  • Stochastic Oscillator
  • RNAC 54.91
  • LMNR 36.22

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: